1-3 of 3
Oleg Fedorov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Inhibitors of MLLT1/3, a Critical Component of the Super-Elongation Complex (SEC), Target a Range of Molecularly Defined Acute Leukemias, with a Differential Profile to Menin Inhibition

John Pollard, Graham Craggs, Gillian Farnie, Matthew Fawkes, Oleg Fedorov, Charline Giroud, Fenella Gross, Joe Harman, Alison Maloney, Thomas Arthur Milne, Iain Simpson
Journal: Blood
Blood (2023) 142 (Supplement 1): 2789.
https://doi.org/10.1182/blood-2023-186638
Published: 2023
Journal Articles

EMT-like Activation in CLL Provides Novel Therapeutic Target

Charlott Repschlaeger, Mariette Odabashian, Filomena Spada, Zamzam Almutairi, John G. Gribben, Francesco Forconi, Emre Sayan, Alexessander Couto Alves, Charline Giroud, Oleg Fedorov, Marina Kriajevskaia, Sergey Krysov
Journal: Blood
Blood (2022) 140 (Supplement 1): 12375–12376.
https://doi.org/10.1182/blood-2022-162696
Published: 2022
Journal Articles

Targeting Aberrant Self-Renewal of Leukemic Cells with a Novel CBP/p300 Bromodomain Inhibitor

Angeliki Thanasopoulou, PhD, Katharina Dumrese, Sarah Picaud, PhD, Oleg Fedorov, PhD, Stefan Knapp, PhD, Juerg Schwaller, MD
Journal: Blood
Blood (2014) 124 (21): 3750.
https://doi.org/10.1182/blood.V124.21.3750.3750
Published: 2014